MNT idk what last time Flashcards
Insulin functions and counter-regulatory hormone
Insulin is hormone produced by the beta-cells of the pancreas. It is necessary for use or storage of body fuels / glucagon
glucagon function and counter-regulatory hormone
a hormone produced by the a-cells of the pancreas that causes an increase in blood glucose levels by stimulating the release of glucose from liver glycogen stores / insulin
somostatin function and counter u know what
a polypeptide hormone secreted from the stomach,small intestine,and pancreas that tends to inhibit other gastrointestinal secretions and motility/ft decreases motility of the stomach and intestine and inhibits or regulates the release of severalGI hormones.
lab values to diagnose dm
AIC ≥ 6.5% FPG ≥ 126 2 hour PG ≥ 200 during OGTT In patients with classic symptoms of hyperglycemia or hyperglycemic crisis, a random PG ≥ 200
Diagnosis for gdm
plasma glucose level of 140/dl/mg
gtt
fasting 95 mg/dl
6.5
diagnosis for igt
the 2-hour blood glucose is between 140 and 199 mg/dl.
What weeks in the pregnancy we test for GDM?
24-28 weeks
Explain why decrease CHO in the morning is needed.
to CHO not as well tolerated at breakfast due to
increased cortisol and growth hormones
What are the recommendations of grams for CHO for the morning?
30 g
Characteristics for type 1 dm
Primary defect is pancreatic beta-cell destruction which leads to absolute insulin
deficiency.
Beta-cell destruction rates vary person to person but typically faster in infants
and children.
Pancreas produces much more insulin than is needed, so possible destruction of
beta-cells starts occuring months or years before symptoms occur. Hyperglycemia
doesn’t occur until > 90% of insulin secretory beta-cells are destroyed.
Immune-mediated diabetes mellitus: autoimmune destruction of
beta-cells in pancreas or idiopathic
auto-immune, environmental, genetic
characteristics of type 2 dm
Insulin resistance
• Target tissues: muscle, liver, adipose cells
Pancreatic beta-cell failure
• May increase secretion of insulin at first to compensate for resistance
• Eventually it will not be able to keep up
Age ≥ 45
Ethnicity: African American, Hispanic, Native American, Asian American, Pacific
Islander
Family History (parents and siblings)
HDL ≤ 35 and TG ≥ 250
HTN
Obesity with BMI ≥ 25
History of IFG or IGT
Vascular
insulin
U- 100 concentration = 100 units of insulin per ml of fluid
Onset – when it starts working
Peak – most action
Duration – how long
Injections via syringe or pen
RAPID ACTING
Examples: Insulin lispro (Humalog)
• Insulin aspart (Novolog)
• Insulin glulisine (Apidra)
• Onset: < 15 minutes
Peak: 60 – 90 minutes
Duration: 3 – 5 hours
Less hypoglycemic episodes than regular
REGULAR INSULIN
Short acting
Onset: 30 – 60 minutes
Peak: 2 – 3 hours
Duration: 5 – 8 hours
Take 30 – 60 minutes before meals
Example: Humalog R
INTERMEDIATE-ACTING
Neutral protamine Hagedorn (NPH) – only one that is
available
Cloudy appearance
Onset: ~ 2 hours
Peak: 6 – 10 hours
Duration: 10 – 16 hours
LONG-ACTING INSULIN
Slow dissolution at injection site – makes it relatively constant and has
peakless delivery over 24 hours
Acidic – so can’t mix with others
Given at bedtime – important that it is given at consistent time daily
Ex: Insulin glargine (Lantus)
Insulin determir (Levemir) – absorbed from tissues quickly and then is
bound to albumin in bloodstream. Prolonged action of 17 hours
lispro - All have an onset of action within
15 minutes, a peak in activity at 60 to 90 min, and a duration of action of 3 to 5 hours. They result in fewer hypoglycemic episodes compared with regular insulin.
regular - is a short-acting insulin with an onset of action 15 to 60 minutes after injection and a duration of action ranging from 5 to 8 hours. For best results the slow onset of regular insulin requires it to be taken 30 to 60 minutes be- fore meals.
NPH - NPH is the only available intetmediate-aaing insulin (Lente insulin has been discontinued). Its appearance
is cloudy,and its onset of action is about 2 hours after injection, with a peak effect from 6 to 10 hours.
basal - analog that becauseof its slow dissolution at the injection site results in a rela- tively constant and peaklessdelivery over 24 hours
insulin - combination rapid acting or short acting pumped continuous with bolus
Insulin secretagogues Sulfonylureas
drugs administered orally to lower blood glucose levels/ katp channel of pancreatic beta cells
Sulfonylureas: promote insulin secretion by beta cells of the
pancreas
Disadvantages: weight gain and hypoglycemia
Examples:
• Glipizide (Glucotrol)
• Glyburide (Glynase Prestabs)
• Glimepiride (Amaryl)
Meglitinide
lower blood levels /pancreatic beta cells
secretagogues
Biguanide
enhance insulin action / liver
metaformin